SCHEMBL22928409

SCHEMBL22928409

O=S12(c3ccccc3-c3cc(-c4ccc(N(c5ccccc5)c5ccccc5)cc4)ccc31)c1ccccc1-c1cc(-c3ccc(N(c4ccccc4)c4ccccc4)cc3)ccc12

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 3/20 0.38
▸ MAPT P10636 2/20 0.38
▸ MEN1 O00255 2/20 0.38
▸ KMT2A Q03164 2/20 0.38
▸ ATM Q13315 2/20 0.38
▸ APAF1 O14727 1/20 0.38
▸ NPC1 O15118 1/20 0.38
▸ LMNA P02545 1/20 0.38
▸ THRB P10828 1/20 0.38
▸ XBP1 P17861 1/20 0.38
▸ PTBP1 P26599 1/20 0.38
▸ HTT P42858 1/20 0.38
▸ RAB9A P51151 1/20 0.38
▸ GALK1 P51570 1/20 0.38
▸ BLM P54132 1/20 0.38
▸ SMAD3 P84022 1/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ NPSR1 Q6W5P4 1/20 0.38
▸ APP P05067 2/20 0.36
▸ ALDH1A1 P00352 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22928711 0.85 METAP2 (0.30) —
SCHEMBL22928233 0.82 MAPT (0.36) L3MBTL1MAPTMEN1KMT2AATM
SCHEMBL22928219 0.76 MEN1 (0.33) L3MBTL1MAPTMEN1KMT2AATM
SCHEMBL22928185 0.76 PDE6D (0.40) L3MBTL1MAPTMEN1KMT2AATM
SCHEMBL25406829 0.73 NPC1 (0.59) L3MBTL1MAPTMEN1KMT2AATM
SCHEMBL30065447 0.73 NPC1 (0.59) L3MBTL1MAPTMEN1KMT2AATM
SCHEMBL30065444 0.73 NPC1 (0.59) L3MBTL1MAPTMEN1KMT2AATM
SCHEMBL30648611 0.72 MEN1 (0.73) L3MBTL1MAPTMEN1KMT2AATM
SCHEMBL29092232 0.72 MEN1 (0.73) L3MBTL1MAPTMEN1KMT2AATM
SCHEMBL27823548 0.72 NPC1 (0.62) L3MBTL1MAPTMEN1KMT2AATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11780831-B2 Compound, display panel and display apparatus Shanghai Tianma AM-OLED Co., Ltd. (CN) 2023-10-10 — — US disclosed
US-11780831-B2 Compound, display panel and display apparatus Shanghai Tianma AM-OLED Co., Ltd. (CN) 2023-10-10 — — US disclosed
US-20210024511-A1 COMPOUND, DISPLAY PANEL AND DISPLAY APPARATUS Shanghai Tianma AM-OLED Co., Ltd. (CN) 2021-01-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210024511-A1 COMPOUND, DISPLAY PANEL AND DISPLAY APPARATUS C1S, DRD1, DRD3 L3MBTL1 1207/4885MAPT 3246/4885MEN1 906/4885
US-11780831-B2 Compound, display panel and display apparatus C1S, DRD1, DRD3 L3MBTL1 1207/4885MAPT 3246/4885MEN1 906/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback